Search results
Emilia Clarke says she was scared of being fired from ‘Game of Thrones’ after brain aneurysms
The Today Show via AOL· 4 days agoEmilia Clarke has spoken about brain aneurysms during her time as Daenerys Targaryen on "Game of...
Emilia Clarke Thought She'd 'Die On Live TV' After Multiple Brain Surgeries
Women's Health via Yahoo News· 5 days ago'Game of Thrones' actress Emilia Clarke had two brain aneurysms, one in 2011 and the other in 2013....
Why Emilia Clarke Feared She Would Get Fired From Game of Thrones After Having Brain Aneurysms - E!...
E! Online· 4 days agoThe Solo alum first detailed balancing a serious health scare with her burgeoning career in a...
Emilia Clarke Feared Being Fired from ‘Game of Thrones’ After Brain Injury
Us Weekly via AOL· 5 days agoEmilia Clarke is revealing how she felt when she experienced twobrain injuries during her time on...
Are strokes hereditary? Research and more
Medical News Today· 1 day agoA stroke occurs due to a blockage of blood flow to a region in the brain or sudden bleeding in the brain. Having a family history of stroke may increase...
ECT for depression: Benefits, risks, and procedure
Medical News Today· 5 days agoElectroconvulsive therapy (ECT) is an alternative treatment for people with depression who have not responded to standard medication. Depression is a...
Kate Middleton apologizes for absence, Taylor Swift helps fan at concert
Fox News· 4 days agoThe Fox News Entertainment newsletter brings you the latest Hollywood headlines, celebrity...
Valley Hospital adds state-of-the-art imaging tech
NJBIZ· 2 days agoFresh off the move to its new Paramus location, The Valley Hospital recently added the latest technology for patients experiencing complex neurovascular...
...LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing...
Morningstar· 6 days agoTOKYO and CAMBRIDGE, Mass., June 09, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”)